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Evolution of high pathogenicity 
of H5 avian influenza virus: 
haemagglutinin cleavage site 
selection of reverse-genetics 
mutants during passage in chickens
Jasmina M. Luczo1,2,3, Mary Tachedjian  1, Jennifer A. Harper1, Jean S. Payne1, 
Jeffrey M. Butler1, Sandra I. Sapats1, Suzanne L. Lowther1, Wojtek P. Michalski1, 
John Stambas2 & John Bingham  1
Low pathogenicity avian influenza viruses (LPAIVs) are generally asymptomatic in their natural avian 
hosts. LPAIVs can evolve into highly pathogenic forms, which can affect avian and human populations 
with devastating consequences. The switch to highly pathogenic avian influenza virus (HPAIV) 
from LPAIV precursors requires the acquisition of multiple basic amino acids in the haemagglutinin 
cleavage site (HACS) motif. Through reverse genetics of an H5N1 HPAIV, and experimental infection of 
chickens, we determined that viruses containing five or more basic amino acids in the HACS motif were 
preferentially selected over those with three to four basic amino acids, leading to rapid replacement 
with virus types containing extended HACS motifs. Conversely, viruses harbouring low pathogenicity 
motifs containing two basic amino acids did not readily evolve to extended forms, suggesting that a 
single insertion of a basic amino acid into the cleavage site motif of low-pathogenic viruses may lead 
to escalating selection for extended motifs. Our results may explain why mid-length forms are rarely 
detected in nature. The stability of the short motif suggests that pathogenicity switching may require 
specific conditions of intense selection pressure (such as with high host density) to boost selection of 
the initial mid-length HACS forms.
Since the emergence of the Eurasian-lineage H5N1 highly pathogenic avian influenza virus (HPAIV) in 1996, 
there has been continued spread and evolution of the virus. HPAIVs with Eurasian-lineage genes are now 
endemic in poultry in several countries including Vietnam, Indonesia, Bangladesh, India, China and Egypt1,2. 
Human infections with Eurasian H5N1 HPAIV were first detected in 1997, and of the 18 cases identified during 
the initial outbreak, six died from the infection3. Phylogenetic analysis traced the haemagglutinin gene lineage 
back to a progenitor virus of avian origin, A/goose/Guangdong/1/1996 (H5N1)4 and, to date, all human H5N1 
HPAIV infections have originated from this Eurasian lineage5,6. Currently, human infections with H5N1 are 
associated with a 52% laboratory-confirmed case fatality rate3,7. HPAIV has the potential to cause widespread 
morbidity and mortality if it acquires the ability to sustain human-to-human transmission.
Infectivity of influenza viruses is dependent on numerous viral and host factors, such as expression of appro-
priate receptors in addition to receptor binding specificity8. However, proteolytic cleavage of the virus surface 
glycoprotein, the haemagglutinin (HA), plays a critical role9. The haemagglutinin cleavage site (HACS) motif of 
low pathogenicity avian influenza viruses (LPAIVs) typically contain one or two non-consecutive basic amino 
acid residues that are cleaved by trypsin and trypsin-like proteases with monobasic specificity9–15. Replication 
of LPAIVs is generally confined to trypsin-expressing epithelial cells16 of the respiratory and gastrointestinal 
tracts17,18. In contrast, the HACS motif of HPAIVs contains multiple basic amino acids18,19, facilitating cleavage by 
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ubiquitously expressed proteases, most notably furin, with polybasic specificity20,21. This allows HPAIVs to repli-
cate in multiple tissues, with a predilection in the chicken for replication in vascular endothelium17,22–28, which is 
considered to be a major factor responsible for high pathogenicity in this species.
Highly pathogenic avian influenza viruses evolve in high density chicken populations found in intensive com-
mercial production systems29–31. For this reason, it is highly appropriate that cleavage site motif mutation and 
evolution of pathogenicity be studied in chickens. Analysis of naturally occurring H5N1 HACS motifs revealed 
a predilection for H5 HPAIVs to evolve to harbour seven basic residues in the HACS motif19, although viruses 
with fewer basic residues in the HACS motif can also be shown to exhibit similar high pathogenicity in chickens32. 
Importantly, removal of the HPAIV polybasic HACS (pHACS) motif by reverse genetics abrogates the ability of 
the virus to replicate in vascular endothelium and cause severe disease27,33–36. Several residues within the pHACS 
motif have been implicated as being critical to the pathogenicity of HPAIVs, in particular, the presence of basic 
residues at P1, P2, P4 and P635,37–40. Despite this knowledge, the mechanism by which pHACS motifs evolve from 
shorter precursors is currently unknown.
The study described here investigated the process by which H5 avian influenza viruses evolve to acquire high 
pathogenicity. A panel of related Asian H5N1 HPAI viruses, derived from the parental A/Viet Nam/1203/2004 
strain and differing only in their HACS motif, was generated by reverse genetics and evaluated for pathogenicity 
in chickens. Sequencing of rescued viruses isolated from chickens indicated fitness peaks at either a low path-
ogenic HACS motif (≤2 non-consecutive amino acids), or extended HACS motif (≥5 basic residues). We also 
tested the hypothesis that, given a suitable viral backbone, an H5N1 virus could rapidly evolve to higher patho-
genicity if more than two basic residues were present within the HACS motif. The resultant viral pathotypes were 
assessed by multiple methods: (1) clinical pattern of infection in chickens, including time to death and clinical 
signs, and (2) pathogenesis of infection as determined by histopathological lesions and cell tropism of the virus. 
This knowledge contributes to the understanding of the molecular markers involved in HPAIV pathogenicity and 
the pathogenesis and evolution of viruses in avian hosts. It enhances our ability to predict the evolution of H5 
high pathogenicity and to mitigate the potential for spillover events to humans.
Results
A panel of viruses, derived from A/Viet Nam/1203/2004 (H5N1), were rescued by reverse genetics, differing 
only by their HACS motif sequence (Table 1). HA deduced amino acid sequences of viral stocks were verified 
by Sanger sequencing prior to infection studies. Engineered viruses were classified as harbouring the following 
HACS motifs: (1) short HACS motif (≤2 non-consecutive basic amino acid residues: rgLPAIV), (2) mid-length 
HACS motif (3–4 basic residues: Mutants 5, 6, and 7) and (3) extended HACS motif (≥5 basic residues: rgHPAIV, 
Mutants 1, 2, 3, 4, 8, and 9).
In silico modelling of the H5 HA structure predicts efficient enzyme access and cleavage for 
extended HACS motifs. To predict the effect of introduced mutations on the structure of monomeric HA, 
protein homology modelling was performed using SWISS-MODEL41–43. The crystal structure of an H3 HA (PDB 
ID: 1HA044) features a HACS motif in the precursor (uncleaved) state. For comparisons of rgHPAIV HA and 
engineered HA structures, with a particular focus on the HACS motif, this 1HA0 template adequately represents 
the native structure at this site, and therefore was selected as the template.
The predicted HA structures of rescued HPAIV virus (rgHPAIV) and engineered HA loops that harbour the 
HACS motif are solvent exposed and exhibit a degree of spatial variation (Fig. 1). Solvent exposure of the HA 
loops is anticipated to facilitate accessibility to, interaction with, and subsequent optimal cleavage by host cell 
proteases. The predicted HA loop structures of mutants M5, M6 and M7 are congruent with the predicted loop 
structure of rgLPAIV, although these viruses are predicted to be cleaved by furin (Supplementary Table S1). These 
mutant viruses with mid-length HACS motif may therefore exhibit sub-optimal interactions with furin, leading 
to decreased HA cleavage efficiency. The predicted HA loop structures of mutants M1, M2, M3, M4, M8 and M9 
Reverse 
genetics virus
HACS motif a
HA1 HA2
P12 P11 P10 P9 P8 P7 P6 P5 P4 P3 P2 P1 P1’
rgHPAIV N S P Q R E R R R K K R G
rgLPAIV N S P Q R E — — — — T R G
Mutant 5 N S P Q R E — — — — K R G
Mutant 6 N S P Q R — — — — K T R G
Mutant 7 N S P Q — — — — R K K R G
Mutant 4 N S P Q R E — — R K K R G
Mutant 8 N S P Q — — — R R K K R G
Mutant 9 N S P Q R E — R R K K R G
Mutant 2 N S P Q R E R R R K T R G
Mutant 1 N S P Q R E R R Q K K R G
Mutant 3 N V P Q R E R R R K K R G
Table 1. Deduced amino acid sequences of engineered HACS motifs of reverse genetics viruses. 1Dash indicates 
deletion, underlined indicates mutation. Cleavage occurs C-terminally at the scissile bond between P1 (HA1) 
and P1’ (HA2). The HACS motif is flanked N-terminally by PQ, and C-terminally by G.
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resemble the larger rgHPAIV solvent exposed loop, albeit with variation, which is likely to facilitate increasingly 
optimal accessibility and cleavage of the HACS motif by furin, suggesting that they are likely to exhibit high path-
ogenicity in chickens.
H5 viruses expressing modified HACS motifs exhibit one of two pathotypes in chickens. After 
generating reverse genetics viruses with various HACS motifs, pathogenicity in chickens was assessed. Inoculation 
of specific-pathogen free (SPF) chickens with rgHPAIV and mutants M1-M9 resulted in a peracute, fulminant 
disease consistent with HPAIV infection18,27. All chickens died within 48 hpi, although the majority died approx-
imately 24 hpi. Chickens inoculated with mutants M1, M3–M7 exhibited significant prolonged survival times 
compared to rgHPAIV (M1 and M4, P < 0.01; M3, M5, M6 and M7, P < 0.001, sham inoculated, P < 0.0001), 
indicative of altered in vivo replication kinetics (Fig. 2, Table 2). Moreover, viral shedding from the oropharyn-
geal and cloacal routes also reflects the altered disease dynamics and delayed in vivo replication kinetics. While 
chickens inoculated with M1, M3-M7 had mean swab viral titres lower than rgHPAIV, chickens inoculated with 
M1 and M5 demonstrated noticeably reduced shedding from the oropharyngeal and cloacal routes at 24 hpi 
(Supplementary Fig. S1).
Clinical disease signs included lack of eating/drinking, diarrhoea, ruffled feathers, listlessness, slow response 
time upon disturbance, isolation from the flock, sleepiness, drooping of the head, increased respiratory rate, 
huddling, severe depression and recumbency. Additionally, swelling of the eyelids and face, red conjunctivae 
and reddening of facial skin were commonly observed. Petechial haemorrhages were observed on facial skin, 
skeletal muscle and cardiac muscle. Transient neurological signs manifested in one chicken (M6, chicken #16). 
One chicken lacked clinical disease signs until convulsing prior to death (M9, chicken #26) and two chickens 
were found dead without observation of clinical signs (M6, chicken #18; M9, chicken #23). Three chickens (M5, 
chicken #7; M8, chicken #46; M1, chicken #10) were clinically healthy at the time of euthanasia.
In contrast to disease manifestation following inoculation with highly pathogenic viruses, inoculation of 
chickens with rgLPAIV resulted in no or mild clinical disease (Fig. 2, Table 2). Mild clinical disease signs included 
ruffled feathers and oedema of the eyelids (two of six chickens). One chicken (#93) exhibited ruffled feathers, 
Figure 1. Homology model structure predictions of HA monomeric glycoproteins of rgHPAIV and engineered 
viruses. Protein tertiary structure prediction of engineered HA glycoprotein was performed by homology 
modelling (see text for details). The crystal structure of 1HA0, with intact loop structure, was used for template 
generation of predicted homology structure models. (A) Overlay of 1HA0, rgHPAIV and rgLPAIV (1HA0: 
gold; rgLPAIV: cyan; rgHPAIV: dark teal). Filled black arrowhead indicates 1HA0 and rgLPAIV loops; unfilled 
arrowhead indicates rgHPAIV loop. 1HA0 template carbohydrate moieties are indicated. (B) Overlay of 
predicted rgHPAIV and engineered HA monomers; loop structure that contains HACS motif is indicated in 
box (rgHPAIV, dark teal; rgLPAIV, cyan; M5, light green; M6, dark green; M7, purple; M4, light teal; M8, pink; 
M9, Red; M2, blue; M1, lilac; M3, dark orange). HA loop structures of mutants M5, M6 and M7 are congruent 
with the predicted loop structure of rgLPAIV; HA loop structures of M1, M2, M3, M4, M8 and M9 resemble the 
larger rgHPAIV loop structure, albeit, with variation. (C) Side view of predicted HA loop structures containing 
the HACS motif. D) Distal view of predicted HA loop structures containing the HACS motif. For (C) and (D) 
rgLPAIV and rgHPAIV predicted loop structures indicated by filled and unfilled arrowheads, respectively.
www.nature.com/scientificreports/
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drooping of the head and tail, hunched posture and neurological signs (mild torticollis, head twitching and 
ataxia). The latter was euthanased for welfare reasons.
H5 highly pathogenic viruses exhibit high replicative capacity in multiple tissues. Our next 
objective was to compare replicative capacity of the viruses within tissues. Infectious virus was isolated from 
brain, spleen, lung and heart tissue excised from all HPAIV infected chickens 24–48 hpi (rgHPAIV, mutants 
M1-M9). Variation in tissue loads between challenge groups was not statistically significant. Generally, the great-
est viral loads were detected in the spleen of all HPAIV inoculation groups, whereas the lowest viral loads were 
detected in brain tissue (Supplementary Fig. S2). The individual chickens that lacked clinical disease signs at the 
time of euthanasia (M5, #7; M8, #46; M1, #10) were positive for infectious virus in tissues, although these had the 
lowest virus titres in all within-group tissues analysed. Our results indicate that the replicative capacity in chicken 
tissues is similar across the HPAIV groups.
Following inoculation of chickens with rgLPAIV, infectious virus was isolated only from brain and lung tis-
sue of chicken #93, which exhibited neurological sequelae and was humanely euthanased at 7 dpi. No virus was 
detected in tissues of remaining chickens, which were euthanased healthy at 14 dpi.
Pathogenicity of HPAIVs in chickens correlates with endothelial tropism. Endothelial tropism is 
a feature of HPAI disease in chickens, which is thought to be a major determinant of high pathogenicity in this 
species17,22–28. To support the view that the pathogenicity of HPAIVs is based on endothelial tropism in our treat-
ment groups, we assessed vascular tropism using immunohistochemistry.
Nucleoprotein viral antigen was observed in all organ systems examined (Supplementary Table S2). Antigen 
derived from highly pathogenic viruses (rgHPAIV, mutants M1-M9) was observed in multiple cell types, with 
vascular endothelium the predominant cell type supporting virus replication (Fig. 3). This was the case in all 
Figure 2. Survival curves of chickens following inoculation with reverse genetics generated viruses. Chickens 
were inoculated with ≥2 × 106 TCID50 of infectious allantoic fluid by the ONO route and monitored for disease 
signs. Chickens were euthanased upon displaying neurological signs or manifestation of moderate HPAI-related 
disease signs. M1, M3-M7 exhibited significant prolonged survival times compared to rgHPAIV (M1 and M4, 
P < 0.01; M3, M5, M6 and M7, P < 0.001, sham inoculated, P = < 0.0001).
Reverse 
genetics virus HACS motif n
Morbidity 
(%)
Mortality 
(%)a
Survival time (hrs)
P valuebRange Mean Median
rgHPAIV NSPQ_RERRRKKR/G 6 100 100 21.75–24.25 22.95 22.85 —
rgLPAIV NSPQ_RETR/G 6 33 17 168.00
Mutant 5 NSPQ_REKR/G 6 83 83 31.25–44.75 35.88 32.38*** 0.0005
Mutant 6 NSPQ_RKTR/G 6 100 100 24.50–27.00 25.71 25.63*** 0.0005
Mutant 7 NSPQ_RKKR/G 6 100 100 24.50–44.00 32.42 28.63*** 0.0005
Mutant 4 NSPQ_RERKKR/G 6 100 100 24.00–25.75 24.83 24.88** 0.0033
Mutant 8 NSPQ_RRKKR/G 6 83 83 22.75–25.00 23.67 23.63 0.2354
Mutant 9 NSPQ_RERRKKR/G 6 100 100 24.00–24.25 24.21 24.25 0.0096
Mutant 2 NSPQ_RERRRKTR/G 5 100 100 24.00–25.00 24.25 24.00 0.0371
Mutant 1 NSPQ_RERRQKKR/G 4 75 75 29.25–30.25 29.75 29.75** 0.0038
Mutant 3 NVPQ_RERRRKKR/G 6 100 100 25.25–27.50 26.25 26.13*** 0.0005
Table 2. Morbidity, mortality and survival times of SPF chickens inoculated with engineered reverse genetics 
viruses. aMortality refers to chickens requiring euthanasia at a pre-determined humane endpoint. Clinically 
healthy chickens were euthanased at the termination of the study (rgLPAIV, five of six chickens; M5, one of six 
chickens; M8, one of six chickens; M1, one of four chickens). bComparisons of survival curves with rgHPAIV 
were assessed using Log-rank (Mantel-Cox) test. Due to multiple comparisons, Bonferroni-corrected threshold 
adjusted to 0.004. **P < 0.01, ***P < 0.001.
www.nature.com/scientificreports/
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chickens where highly pathogenic disease manifested. Viral antigen was also common or abundant in neurons 
and astrocytes (Fig. 3A), in mononuclear phagocytic tissue such as spleen (Fig. 3B), in lung parenchyma (Fig. 3C), 
in cardiomyocytes (Fig. 3D) and occasional kidney tubular epithelial cells (Fig. 3E). Antigen was generally rare 
in epithelium, although it was dense within the sub-epithelial vascular network, such as the lamina propria of the 
intestine (Fig. 3F).
In contrast to the widespread tissue tropism exhibited by highly pathogenic viruses, viral antigen was not 
observed in endothelium of rgLPAIV infected tissues. In chicken #93, which exhibited neurological signs, there 
was diffuse focal viral antigen within the neurons of the brain, occasional foci of antigen in the epidermis of the 
comb (Supplementary Fig. S3) and rare antigen in the lungs, the cardiomyocytes and within interstitial inflam-
matory lesions of the kidneys.
Figure 3. Viral antigen in rgHPAIV infected tissues. Influenzavirus A nucleoprotein antigen (brown) detected 
by immunohistochemistry in various tissues. Vascular endothelium of capillaries and larger blood vessels is the 
dominant cell type supporting viral antigen in all tissues (arrowheads). (A) Brain, showing antigen in capillary 
endothelium and also in a focus of neurons and astrocytes (*). (B) Spleen, showing antigen in endothelium 
of arterioles and also associated with non-lymphocytic cells of the splenic parenchyma. (C) Lung, showing 
antigen in vascular endothelium; the main antigen staining is in the rich capillary network of the interstitium. 
(D) Heart, showing antigen in endothelium and in cardiomyocytes, where it is seen as a brown hue within the 
muscle fibres (+). (E) Kidney: antigen is mainly in the interstitial capillaries, but also in occasional tubular 
epithelial cells (arrow). (F) Jejunum, where antigen is present in capillaries within the laminar propria.
www.nature.com/scientificreports/
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HPAIVs with extended pHACS sequences are rapidly selected in vivo. The results heretofore 
describe features of the infection and disease caused by the different reverse genetics viruses and have indicated 
that the disease outcome of all, except rgLPAIV, is consistent with highly pathogenic disease. Given that advanced 
infection is caused not by inoculated virions, but by their progeny following replication and selection, we sought 
to determine the viral HACS motif sequence of the viral population at the time of disease. Nucleic acid extracted 
from infected brain and/or lung tissue, collected at times described above, was amplified by PCR and sequenced 
by Sanger sequencing to determine if additional modifications had occurred within the HACS motif following 
in vivo passage.
Viral HA nucleic acid sequences were undetectable in the lung and brain tissue of rgLPAIV inoculated chick-
ens, with the exception of chicken #93, which had exhibited neurological signs (the HA sequence isolated from 
lung and brain tissue remained unchanged). The pHACS motif of rgHPAIV and other highly pathogenic viruses 
(mutants M2, M3, M4, M8, and M9) isolated from lung and/or brain tissue also remained stable following in vivo 
passage. Mid-length pHACS motifs (mutants M5, M6 and M7) were unstable and incorporated additional basic 
amino acids following in vivo passage (Table 3). There was no variation in nucleic acid sequences isolated from 
lung or brain tissue, suggesting that selection of viruses with extended motifs is not tissue specific.
HPAIVs with mid-length HACS motifs are predicted to have a HA loop structure congruent with the loop 
structure of rgLPAIV (Fig. 1), potentially influencing the fitness of highly pathogenic viruses, as a result of sub-
optimal interactions with furin’s active site. Sequencing of M6 and M7 after in vivo passage revealed insertions of 
basic amino acids in the HACS motif (Table 3), which would serve to increase the stability of the interaction with 
furin. The HACS motif of mutant M1, that initially harboured glutamine at P4, mutated in three of four chickens, 
to incorporate either a leucine, to revert to an arginine, or to incorporate a compensatory lysine at P7 (Table 3). 
The compensatory mutation at P7 (lysine), may serve to reinstate a substrate with sufficient basic amino acids to 
overcome the suboptimal amino acid at P4. Furthermore, it has been reported that aliphatic residues at P4 (such 
as leucine) are tolerated by furin45, likely facilitating the substitution mutation from glutamine to leucine iden-
tified at this position. Sequencing of viruses isolated from M5 inoculated chickens revealed substitutions at P6 
to either basic (histidine) or aliphatic (leucine) amino acids (Table 3). Despite delayed infection kinetics in vivo, 
this did not alter HPAI disease outcome. The HACS motif of all remaining highly pathogenic viruses (rgHPAIV, 
M2, M3, M4, M8, and M9) remained stable following in vivo passage, suggesting that the HACS motif could suf-
ficiently interact with the activating protease, as predicted by the HA loop structures (Fig. 1).
In summary, our HACS motif sequence analysis suggested that viruses harbouring two non-consecutive basic 
residues (rgLPAIV) within a HACS motif were stable upon in vivo passage, as were pHACS motifs harbouring 
five or more basic residues. Viruses harbouring HACS motifs that contained three to four basic residues (mutants 
M5, M6 and M7) or non-basic residues at key positions, rapidly changed to be superseded by viral populations 
incorporating additional basic residues in the HACS motif.
Virus na Parental HACS motif HACS motif post-passageb
rgHPAIV 6 NSPQRERRRKKR/Gaat agc cct caa aga gag aga aga aga aaa aag aga/gga NC
rgLPAIV 6 NSPQRETR/Gaat agc cct caa aga gag ac gaga/gga NC
Mutant 5 6 NSPQREKR/Gaat agc cct caa aga gag aag aga/gga
NSLRREKR/G (n = 5)  
aat agc ctt cga aga gag aag aga/gga  
NSHQREKR/G (n = 1)
aat agc cat caa aga gag aa gaga/gga
Mutant 6 6 NSPQRKTR/Gaat agc cct caa aga aaa acg aga/gga
NSPQRKRKTR/G (n = 6)
aat agc cct caa aga aaa aga aaa acg aga/gga
Mutant 7 6 NSPQRKKR/Gaat agc cct caa aga aaa aag aga/gga
NSPQRRKKR/G (n = 6)  
aat agc cct caa aga aga aaa aag aga/gga
Mutant 4 6 NSPQRERKKR/Gaat agc cct caa aga gag aga aaa aa gaga/gga NC
Mutant 8 6 NSPQRRKKR/Gaat agc cct caa aga aga aaa aag aga/gga NC
Mutant 9 6 NSPQRERRKKR/Gaat agc cct caa aga gag aga aga aaa aag aga/gga NC
Mutant 2 5 NSPQRERRRKTR/Gaat agc cct caa aga gag aga aga aga aaa acg aga/gga NC
Mutant 1 4 NSPQRERRQKKR/Gaat agc cct caa aga gag aga aga caa aaa aag aga/gga
NSPQRERRRKKR/G (n = 1)
aat agc cct caa aga gag aga aga cga aaa aag aga/gga 
NSPQRERRLKKR/G (n = 2)
aat agc cct caa aga gag aga aga cta aaa aag aga/gga 
NSPQRKRRQKKR/G (n = 1)
aat agc cct caa aga aag aga aga caa aaa aag aga/gga
Mutant 3 6 NVPQRERRRKKR/Gaat gtc cct caa aga gag aga aga aga aaa aag aga/gga NC
Table 3. Nucleotide and deduced amino acid sequence of HACS motif of viral inocula and following viral passage 
in chickens. an: number of chickens. bItalicised font indicates insertions. Underlined indicates mutation(s). NC: no 
change. The nucleic acid sequence isolated post-passage was taken from lung and/or brain tissue.
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Initial replication in respiratory epithelium is not an absolute requirement for H5 HACS motif 
expansion. Initial studies revealed that mid-length pHACS motifs were displaced by extended motifs during 
replication in chickens (Table 3). To examine this process in more detail, we compared shifts in viral populations, 
focusing on the HACS motif cDNA sequence, between inocula and following disease onset, using next generation 
sequencing (NGS). We also compared how different routes of inoculation could affect the composition of the 
pHACS motif sequence. To this end, different groups of SPF chickens were inoculated with the same stock of M6 
by either the oronasal-ocular (ONO) or intravenous (IV) route (n = 6 chickens each). This HPAIV challenge virus 
was selected for this study as it harboured a mid-length pHACS motif present in naturally occurring viruses19,46,47, 
is a possible transition species during pathotype conversion, and consistently incorporated additional basic resi-
dues into the HACS motif. In our hypothesis, we expected that the dominant (mid-length) HACS sequence of the 
inoculum would be given a more favourable opportunity to replicate sustainably and be detected if inoculated IV, 
before virions with extended-length sequences became the dominant type.
Chickens inoculated with M6 by the ONO (n = 6) and IV (n = 6) route displayed peracute, fulminant clini-
cal signs typical of HPAI infection: infrequent eating and drinking, ruffled feathers, diarrhoea, listlessness, slow 
response time upon disturbance, isolation from the flock, sleepiness, huddling, drooping of the head, severe 
depression and recumbency. Median survival times of chickens inoculated by the ONO and IV routes were 
26.0 and 16.3 hrs, respectively (Fig. 4), a difference that was statistically significant (Log-Rank (Mantel-Cox) 
test, P = 0.0007). Viral antigen was observed in all organ systems examined (Supplementary Table S3). 
Histopathological signs were consistent with HPAI disease and immunohistochemistry confirmed the presence 
of viral antigen in endothelium for all chickens in both M6 inoculated groups.
Sequencing of viral nucleic acid extracted directly from infected brain tissue of both M6 challenge groups 
revealed a duplication event within the HACS motif, consisting of an insertion of 6 nucleotides between residues 
1012 and 1013, leading to the insertion of arginine and lysine (aat agc cct caa aga aaa acg aga/gga encoding 
N-S-P-Q-R-K-T-R/G → aat agc cct caa aga aaa a ga aaa acg aga/gga encoding N-S-P-Q-R-K-R-K-T-R/G, Table 3). 
The insertion was also detected at a low frequency (<5%) in the inoculum. Selection of viruses encoding arginine 
and lysine insertion was highly favoured and rapidly selected in vivo, and the disease outcome of this selection 
replicated our findings in the original trial with M6 (Table 3). The duplication in the HACS motif was detected in 
brain tissue of all chickens inoculated by ONO (n = 6) and IV (n = 6) routes, constituting 98.4–99.3% and 98.3–
98.9% of viral nucleic acid sequences, respectively. This suggests that initial replication in mucosal epithelia is not 
an absolute requirement for selection of viruses with expanded HACS motifs, and that the vascular system does 
not differentially favour mid-length sequences.
The H5 LPAIV HACS sequence motif is highly stable, even in the presence of strong selection 
pressure. We have demonstrated that incorporation of a single basic amino acid into a LPAIV motif may 
drive motif extension and conversion to high pathogenicity. Next, we wanted to show if low pathogenic variants 
(those with only two, non-consecutive, basic amino acids in the HACS) would be as prone to sequence extension, 
given the optimal conditions for doing so. Our premise was that highly pathogenic variants replicate predomi-
nantly in the ideal environment of the vascular compartment; if the mucosa is a barrier to entry into the vascu-
lar compartment, then direct IV inoculation can evade this barrier and favour pathotype switching. Therefore, 
inoculation of virus directly into the blood would help to drive this selection; in addition, inoculation of larger 
numbers of chickens would also raise the likelihood of conversion. To this end, we inoculated chickens by the IV 
(n = 10) and ONO routes (n = 25) and observed them for infection and disease.
Clinical signs were similar for both the ONO and IV groups inoculated with rgLPAIV, and included diarrhoea, 
drooping of the head, ruffled feathers, sleepiness and cyanosis of the comb. Morbidity was evident in 32% (8 of 25) 
and 80% (8 of 10) chickens in the ONO and IV group, respectively, and all but one (#28, IV inoculation) presented 
with neurological signs, including head twitching, torticollis, ataxia and paralysis. One chicken (#28) from the IV 
group required euthanasia at 2 dpi with HPAI-like clinical signs, including severe depression and recumbency, 
but with no neurological signs. Sequence analysis of virus re-isolated from the brain of chicken #28 identified a 
H5 LPAIV HACS motif. The survival curves are shown in Fig. 4. The median time from challenge to the onset of 
disease, in those chickens that developed HPAI-like or neurological disease were 196.4 (range: 120.0–240.5) and 
Figure 4. Survival curves of chickens following challenge with M6 or rgLPAIV (second challenge trials). 
Chickens were inoculated with ≥2 × 106 TCID50 mutant M6 (A) or rgLPAIV (B) by the oronasal-ocular (filled 
circles) or intravenous (unfilled circles) route, and monitored for disease signs. Chickens were euthanased upon 
displaying neurological signs or manifestation of moderate HPAI-related disease signs.
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144.0 hpi (range 47.0–262.3) for ONO and IV inoculation routes, respectively (t-test, P = 0.3468). Additionally, 
the frequency of neurological disease presentation did not significantly differ between ONO and IV inoculation 
routes (Fisher’s exact test, P = 0.0619).
Tissue tropism of rgLPAIV infection was not influenced by the inoculation route (Supplementary Table S3). 
Viral antigen was found to occur mainly in the epithelium of the kidney, in association with tubular degeneration 
and mononuclear cell interstitial nephritis, and in the epithelium of the nasal gland and infra-orbital sinus. All 
ONO and IV rgLPAIV inoculated chickens that displayed neurological signs were found to have histopathological 
lesion(s), viral antigen, and/or infectious virus in brain tissue. Neurological signs and neural lesions were asso-
ciated with mild perivascular cuffing and glial response. Viral antigen within the brain was restricted to neuron 
cell bodies and astrocytes. Virus replication within vascular endothelium was observed only in one chicken (#28), 
which was challenged by the IV route and euthanased at day 2 pi. In this bird, viral antigen was observed at low 
levels within capillary endothelium in heart tissue and dermis of the comb; viral antigen was also present in car-
diomyocytes. However, sequence analysis of virus re-isolated from this bird and others in the trial indicated that 
the virus maintained a LPAIV HACS motif.
Next generation sequencing performed on oropharyngeal swabs (n = 4) or brain tissue (n = 4) extracted from 
rgLPAIV inoculated chickens revealed that the viral population maintained a LPAIV HACS motif following 
in vivo passage, indicating that the HACS motif is stable, even in the presence of strong selection pressure. 
A mutation flanking the HACS motif was detected in one chicken (#26,), resulting in a PQ_RETR/G → LQ_
RETR/G substitution (1010 c > t single nucleotide polymorphism (SNP) detected in 1.1% of sequences), further 
indicating possible tolerance of aliphatic residues at P648. NGS performed on brain tissue extracted from chickens 
that exhibited neurological signs revealed an enrichment of the 377 a > g/c (N126T/S) SNP in the neuraminidase 
gene. This SNP constituted 1.3% (377 a > c; N126T) and 4.1% (377 a > g; N126S) of viral species in the inocula, 
and was enriched up to 99.98% of viral sequences detected. Of the two amino acids encoded by the SNP at 
position N126T/S, the presence of Ser (63.7–99.9% of species; detected in 8/8 rgLPAIV NGS samples) seemed 
to confer a greater fitness advantage in chickens than Thr (7.2–22.9% of species, detected in 5/8 rgLPAIV NGS 
samples). This SNP results in the loss of a predicted N-glycosylation site, which has been previously associated 
with neurovirulence of influenza A virus in mice (A/WSN/1933) (Asn146, N2 numbering)49.
These results indicate that no reversion to a HPAI pathotype or a highly pathogenic HACS motif occurred in 
rgLPAIV inoculated chickens. Despite one rgLPAIV inoculated chicken displaying clinical and pathological signs 
consistent with HPAIV infection, a HACS motif consistent with H5 LPAIV was maintained. The H5N1 LPAIV 
sequence is evidently highly stable and confers a high fitness advantage within the A/Vietnam/1203 backbone.
Discussion
In this study, we examined the molecular pathogenesis and evolution of H5N1 HPAIV HACS motif from low 
pathogenic precursor viruses. Our findings inform the evolution of H5 viruses, but to a lesser extent H7 influ-
enza viruses – the other principle subtype that develops high pathogenicity in chickens – as the H7 cleavage 
site motif has significant differences in its motif structure. Utilising a reverse genetics approach and the A/Viet 
Nam/1203/2004 Eurasian clade 1 H5N1 HPAIV, we systematically generated recombinant viruses harbouring 
HACS motifs with differences in the number of basic residues, or mutations at select sites, and compared their 
infection dynamics in chickens. Although previous studies have investigated the influence of variations of the 
HACS motif on influenza pathogenicity27,33–40,50,51, our study comprehensively performed systematic mutagen-
esis of the H5 HACS motif to assess the influence of HACS length and composition on H5N1 pathogenicity, 
pathogenesis, viral fitness and evolution in chickens. Our findings indicate that in chickens, there is relatively 
minor selection pressure on monobasic (LPAIV) and extended pHACS (HPAIV) sequences, however, mid-length 
pHACS are rapidly replaced by extended forms. This not only implies that in chickens, viruses harbouring LPAIV 
or HPAIV HACS motifs exhibit high viral fitness, but also that viruses harbouring mid-length pHACS motifs 
exhibit low fitness and are of a transient nature. Similar selection pressure may apply to avian influenza viruses 
under natural conditions and may explain some of the variation and pathogenicity seen with field isolates.
Our results are consistent with the low frequency of mid-length HACS motifs and the higher frequency of 
monobasic LPAIV and extended HPAIV pHACS motifs found in nature19. LPAIVs are commonly isolated from 
domestic and wild waterbirds and also in domestic gallinaceous species52. They are adapted for mucosal replica-
tion and transmission through the faecal-oral route and, as they are generally innocuous, they are able to main-
tain a fitness advantage with minimal genetic change. In contrast, viruses with extended pHACS motifs replicate 
with maximal efficiency within the host’s parenchymal tissues, causing acute, severe disease. Mid-length HPAIV 
pHACS motifs are not preferred as selection favours extended sequences. Of interest is whether continued pas-
sage of mutant viruses would result in further expansion of the HACS motif to yield viruses that harbour seven 
basic amino acids in the HACS motif, which seems to represent a fitness peak for naturally occurring HPAIVs19.
We measured pathogenicity by clinical signs, time of onset of morbidity, and tropism for vascular endothe-
lium. Pathogenicity for AIV is usually scored using a measure of chicken mortality53. For this study, we incor-
porated endotheliotropism as an additional marker to better reflect overall pathogenesis. Endotheliotropism is 
a marked feature of H5N1 HPAIV replication in gallinaceous species18,22–25,27,28,54,55 and is the principle deter-
minant of pathogenicity. This predilection for replication in endothelial cells can be annulled by removal of 
the pHACS27,33–36, indicating that the pHACS motif is a major determinant of endothelial tropism. Our study 
revealed a clear correlation between pathogenicity and the ability of the virus to replicate in vascular endothe-
lium. Incorporation of one additional basic residue into the LPAIV HACS, to form a mid-length pHACS motif, 
was sufficient for pathotype conversion, with appearance of high mortality and endothelial tropism.
Wild type LPAIVs do not usually replicate in vascular endothelium, but will typically replicate in epithelium, 
particularly of the respiratory tract and kidneys, and this type of infection leads to limited disease. Such infection 
was observed in chickens infected with rgLPAIV in this study, with antigen observed in the nasal glands and 
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kidney epithelium of some birds. However, we also observed replication in brain, with manifestation of neurolog-
ical signs. This is not typical of LPAIV infection, and emphasises that the rgLPAIV is an artificial construct that 
may not be fully representative of naturally occurring LPAIV forms. Its replication in brain and other parenchy-
mal tissues indicates that the HA protein is able to be cleaved, albeit inefficiently, in tissues that are not thought to 
produce trypsin-like enzymes. Moreover the N126S/T neuraminidase mutation identified functions to sequester 
plasminogen, leading to cleavage of HA, as has been demonstrated for the equivalent position (N2 numbering: 
N146S/T) of A/WSN/1933 (H1N1)56. Our study also indicates that the virus is able to be spread via the circula-
tion, despite the lack of evidence that it replicates within the vascular system.
As measures of within-host fitness, we determined the survival times of infected chickens, we characterised 
the amount of virus in tissues and we measured the relative frequencies of HACS type through gene sequenc-
ing. Rapid disease progression occurred for viruses with extended pHACS motifs, with longer survival times 
for those with shorter (mid-length) motifs. High viral loads, with minimal variation between challenge groups, 
were detected in visceral organs from chickens inoculated with highly pathogenic viruses. Comparisons between 
viral loads detected in swabs from the oropharynx, and to a lesser extent, the cloaca, revealed a slight positive 
correlation between the number of basic residues within the pHACS motif and quantity of virus in oropharyngeal 
and cloacal fluids. Increasing the number of basic residues within the HACS motif increases the stability of the 
substrate-protease interaction due to an increase in the number of intermolecular hydrogen bonds formed57. 
A fitness advantage is likely conferred as HA is stabilised in the furin substrate-binding domain, facilitating 
increased HA cleavage efficiency. This fitness advantage may be important in the context of a fulminant, peracute 
infection as the ability to shed increased virus loads in a relatively short timeframe is likely to increase the poten-
tial for transmission58. Transmission studies with each of the high pathogenicity viruses would be of interest to 
determine the influence on transmission dynamics and may explain why a large proportion of naturally occurring 
H5 HPAIV isolates harbour an extended pHACS motif.
Extension of the HACS motif to include additional basic residues facilitates cleavage by the ubiquitously 
expressed protease, furin20. Furin’s ability to cleave basic substrates is modulated by the presence of acidic, nega-
tively charged, residues at S1, S2 and S4 within the substrate binding domain59. The presence of additional basic 
residues, which contribute to an increased positive charge in the HACS motif, facilitates interactions with the 
negatively charged (acidic) residues within furin’s substrate binding domain. Increasing the number of basic 
residues in the HACS motif likely stabilises the interaction between furin and HA, leading to increased cleavage 
efficiency. Moreover, the preference for an expanded HPAIV pHACS motif may aid tolerance of rare mutations 
that introduce non-basic residues into the HACS motif during genome replication. Experimental evidence herein 
suggests that mutations at key sites in the H5 HACS motif (P4, M1; P2, M2) were tolerated in vivo, despite having 
a profound detrimental effect on cleavage activation in vitro21,37,39. The presence of multiple basic residues flank-
ing these residues may compensate for sub-optimal interactions at these key sites. However, this may be highly 
dependent on the subtype and molecular sequence of the HACS motif, as mutation of P4 in the H7 HACS motif 
has been demonstrated to modulate pathogenicity50.
The VN1203 backbone used in this study may have contributed to pathotype conversion. The polygenic nature 
of AIV pathogenicity is well documented33,60,61, and VN1203 already possesses the optimal genetic constellation 
for acquisition of pathogenicity. Previously, incorporation of a pHACS motif into a LPAIV H3N8 backbone did 
not facilitate pathotype conversion61. Although H3 AIVs have not been demonstrated to support a highly patho-
genic pathotype, other low-pathogenicity HA subtypes have, including H2, H4, H8 and H1462. Additional HACS 
motif mutagenesis studies utilising H5N1 isolates with various genetic backbones may shed light on whether 
pathotype conversion occurs as rapidly. This information could lead to the identification of optimal genetic con-
stellations for subsequent acquisition of high pathogenicity.
Currently, despite the AIV HACS motif being extensively studied, the mechanisms and selection pressures 
that lead to expansion of the HACS motif in chickens is still unclear. In the present study, mutation events in the 
HACS motif appeared to occur in the chicken embryo in which the inocula were generated. Most of the mutations 
observed were substitutions or insertions of nucleotides encoding for basic amino acids. We hypothesise that the 
mutations observed in the HACS motif are selected within passage in chickens to optimise the interaction of the 
pHACS with furin.
A duplication event was detected in the HACS motif of M6 (PQ_RKTR↓G → PQ_RKRKTR↓G). A similar 
duplication event in the HACS motif was observed during the 1994 Mexico HPAIV outbreak63,64. Also, an inser-
tion of a basic amino acid residue (arginine) was detected in the HACS motif of M7. Polymerase slippage as a 
consequence of HA RNA stem-loop secondary structure has been postulated to facilitating the incorporation of 
additional basic residues into the H5 HACS motif64–66. The mechanism for polymerase slippage is yet to be con-
firmed unequivocally, and as such, viruses that harbour mid-length HACS motifs provide a unique opportunity 
to dissect and confirm the molecular mechanism leading to insertion of additional basic residues in the HACS 
motif. We also observed substitutions (M1, M5) and these appear to have arisen from simple substitution of single 
bases within the codons.
The stability of the short LP motif suggests that it has high fitness in chickens. It is not easily replaced by longer 
motifs, despite experimental procedures, such as IV inoculation, to help incite such events. Therefore, evolution 
of high pathogenicity is not a common event and would require specific conditions, such as high host density, 
to enhance the selection of the initial mid-length HACS forms. But once these mid-length forms are generated, 
this may lead to escalating selection for extended motifs and the rapid emergence of highly pathogenic variants.
In summary, we have characterised the relative fitness of mutations that arise during H5 avian influenza virus 
evolution. Our study highlights that the critical bottleneck in evolution of HPAIVs lies in the switch of LP motifs 
to incorporate a single additional basic amino acid. Upon overcoming this evolutionary constraint, expansion 
of mid-length HACS motifs towards extended forms occurs rapidly. Identification of the molecular mechanism 
driving expansion of the HACS motif would not only lead to a greater understanding of the biology of influenza 
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viruses, it would underpin our understanding of the mechanisms leading to the emergence and evolution of 
HPAIVs from low pathogenic precursors.
Materials and Methods
Cells. Madin Darby canine kidney (MDCK) (ATCC CCL-34) and Vero (ATCC CCL-81) cells were cultured 
in Minimal Essential Medium (MEM), and human embryonic kidney 293 T (HEK293T) cells (ATCC CCL-3216) 
were cultured in Dulbecco’s modified Eagle medium (DMEM). Media was supplemented to a final concentration 
of 10% (v/v) foetal calf serum (FCS), 10 mM HEPES, 2 mM L-glutamine, 100 U/ml benzylpenicillin, 100 µg/ml 
streptomycin, 50 µg/ml gentamicin and 2.5 µg/ml amphotericin B. Cell cultures were maintained at 37 °C with 
5% CO2.
Generation of viruses by reverse genetics. All reverse genetics viruses used in this study were 
derived from H5N1 HPAIV, A/Viet Nam/1203/2004. Mutations were introduced into the pHACS motif using 
QuikChange II-E site-directed mutagenesis kit (Stratagene) according to the manufacturer’s instructions. 
Mutagenesis oligo sequences are available upon request. Reverse genetics rescue of engineered viruses was per-
formed as previously described67. Briefly, co-cultures of MDCK and HEK293T cells were transfected with the 
VN1203 eight-plasmid reverse genetics system using FuGene 6 (Roche). Transfection media was aspirated 6 hrs 
post-transfection, prior to the addition of Opti-MEM media containing 1 µg/ml TPCK-treated trypsin. Tissue 
culture supernatant (TCSN) was harvested 96 hrs post-transfection, clarified by centrifugation and stored at 
−80 °C.
Virus stocks were generated by passage of reverse genetics TCSN in the allantoic cavity of 10-day-old SPF 
embryonated chicken eggs. Infectious allantoic fluid was harvested, clarified by centrifugation and stored at 
−80 °C. The HA gene sequence was verified by Sanger sequencing prior to inoculation of chickens. The deduced 
amino acid sequences of engineered reverse genetics viruses are outlined in Table 1.
Homology structure modelling of engineered HA glycoproteins. Protein homology structure mod-
elling was performed with Swiss-Model (http://swissmodel.expasy.org/)41–43, based on the crystal structure of 
uncleaved influenza A HA0, PDB: 1HA044. Predicted model structures were visualised and manipulated with 
Discovery Studio, version 4.1.0.14169 (BIOVIA).
Animals and ethics statement. All animal experimental protocols were examined and approved by the 
CSIRO AAHL and Deakin University animal ethics committees, and were conducted in accordance with the 
Australian code for the care and use of animals for scientific purposes (Australian National Health and Medical 
Research Council). All embryonated chicken eggs used for virus growth and quantification were 10 days old at 
the time of inoculation.
All animal experimentation was performed in biosafety level 3 (BSL3) facilities, using the appropriate personal 
protective equipment, with powered air purifying respirators.
SPF white Leghorn embryonated eggs (Australian SPF Services) were incubated in a humidified incubator at 
37 °C until hatch and subsequently housed in positive-pressure isolators. Upon reaching desired age, chickens 
were transferred to the BSL3 animal facility for acclimatisation, randomly assigned to groups and pre-inoculation 
samples taken. Challenge groups were housed separately. Food and water were available to chickens ad libitum.
Study design. Initial pathogenesis study of HACS motif mutants. Four to six-week old SPF white Leghorn 
chickens were inoculated with ≥2 × 106 TCID50 infectious allantoic fluid in sterile phosphate buffered saline 
(PBS) by the ONO route (n = 6 birds per group, with the exception of mutants M1, n = 4 and M2, n = 5). Negative 
controls were administered PBS diluent. Virus inocula were back-titrated to confirm the actual dose. Chickens 
were euthanased upon reaching a pre-defined clinical endpoint (moderate disease signs including infrequent 
eating and drinking, fluffed feathers, diarrhoea, sleepiness, depression and huddling) or if, for welfare reasons, 
a chicken was the sole occupant of the room. Pathogenicity was assessed by various methods, including percent 
morbidity and mortality, times to disease, viral loads in tissues, cell tropism, and tissue antigen amounts.
Follow-up studies with M6 and rgLPAIV. Four-week-old SPF white Leghorn chickens were inoculated with 
≥2 × 106 TCID50 mutant M6 by the ONO or IV route (n = 6 per group). Additionally, SPF chickens were inoc-
ulated with ≥2 × 106 TCID50 rgLPAIV by the ONO or IV route (n = 25 and 10, respectively). Viral doses were 
confirmed by back titration of the inocula.
Virus titration. Viral loads were quantified by median tissue culture infectious dose (TCID50) on Vero or 
MDCK cells in the presence of 1 µg/ml TPCK-treated trypsin. Tissue homogenates (~10%) or neat swab media 
(PBS containing 10 µg/ml bovine serum albumin, 500 U/ml benzylpenicillin, 500 µg/ml streptomycin and 50 µg/
ml gentamicin) were serially diluted 10-fold and applied in quadruplicate to cell monolayers. Cytopathic effect 
was assessed five days post infection. Viral titres were calculated based on the Spearman-Karber method68. 
Additionally, the presence of infectious virus was confirmed by allantoic inoculation of triplicate 10-day-old 
embryonated chicken eggs with 100–200 µl of neat swab media or 10% tissue homogenate.
RNA extraction, cDNA synthesis, Sanger sequencing and next generation sequencing. RNA 
was directly extracted from infected allantoic fluid, brain and/or lung tissue using RNeasy mini kit (QIAGEN) 
according to the manufacturer’s instructions. cDNA was synthesised using SuperScript III First-Strand synthesis 
system (Life Technologies) according to manufacturer’s instructions. AAHL in-house gene-specific primers were 
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used to amplify the HA gene segment using high fidelity enzyme. Sanger sequencing was performed directly on 
PCR amplicons.
For NGS, total RNA was extracted from stock allantoic fluids or brain tissue (M6 and rgLPAIV) or oropharyn-
geal swab (rgLPAIV) using MagMAX Total Nucleic Acid Isolation Kit (Thermo Fisher Scientific) and cDNA was 
synthesised as described above. Partial amplification of mutant M6 HA gene (spanning the HACS motif) was 
performed using high fidelity enzyme (Kapa Biosystems) with HA specific primers (available upon request). 
Amplicons were visualised by DNA gel electrophoresis prior to purification. Multiplexing indices and sequencing 
adaptors were incorporated by a second round of PCR (Nextera XT Index Kit, Illumina). M6 amplicon librar-
ies were purified (Ampure XP beads, Beckman Coulter), quantified, normalised and pooled prior to multiplex 
sequencing using 300-bp paired reads on Illumina MiSeq. rgLPAIV whole genome were amplified using high 
fidelity enzyme (Kapa Biosystems) using whole genome primers69. Whole genome libraries were tagmented, and 
multiplexing indices and sequencing adaptors were incorporated in a subsequent round of PCR using Nextera XT 
DNA Sample Preparation Kit (Illumina). Whole genome libraries of rgLPAIV were purified (Ampure XP beads, 
Beckman Coulter), quantified, normalised, pooled and subjected to multiplex sequencing using 250-bp paired 
reads on Illumina MiSeq. In silico NGS data analysis was performed as previously outlined70, with modifications. 
Whole genome sequencing (WGS) read mapping was modified as follows: mismatch, two; insertion/deletion, 
three. WGS variant filtering was modified as follows: independent counts, >10; minimum coverage: >999; aver-
age quality variant, >Q30; variant frequency: >1%. Amplicon read trimming were modified as follows: remove 
reads <200 bases. Amplicon variant filtering was modified as follows: independent counts, >two; average quality 
variant, >Q30; variant frequency, >1%.
Histopathology and immunohistochemistry. Tissue samples harvested at necropsy were placed in 10% 
neutral buffered formalin (Australian Biostain). Preserved tissue samples were processed according to routine 
histological methods before embedding in paraffin wax and sectioning into 4 µm-thick sections.
A rabbit anti-Influenzavirus A nucleoprotein hyperimmune serum (generated in-house by AAHL Bioassay 
R&D Team) was used as the primary antibody to detect viral antigen in formalin-fixed paraffin embedded tissues. 
Tissue sections were deparaffinized before high pH antigen retrieval (Dako, Agilent Technologies) at 97 °C for 
30 min. Endogenous peroxidases were blocked with 3% hydrogen peroxide for 10 min. Tissue sections were incu-
bated with a 1:2,000 dilution of the primary antibody for 60 min, washed with TBS prior to a 20 min incubation 
with anti-rabbit horseradish peroxidase-conjugated secondary antibody (Dako, Agilent Technologies). Viral anti-
gen was visualized by the addition of AEC substrate chromogen (Dako, Agilent Technologies) for 10 min, washed 
with TBS and counterstaining with Mayer’s haematoxylin before visualising by light microscopy.
The presence of influenza nucleoprotein antigen in tissues was assessed by light microscopy. Antigen quanti-
ties were scored according to a four-point scoring system: 0, no antigen; 1, rare antigen; 2, moderate antigen; 3, 
abundant antigen.
Statistical analysis. Statistical analyses were performed using Prism 7, version 7.03 (GraphPad, La Jolla, 
USA). Unless stated otherwise, multiple comparisons were performed using a non-parametric Kruskal-Wallis 
test with a post hoc Dunn’s multiple comparisons test. Comparisons of survival curves was assessed with 
Log-rank (Mantel-Cox) test with Bonferroni-adjusted thresholds due to multiple comparisons. Error bars rep-
resent mean ± 95% confidence intervals (CI). Significance levels for are expressed as: *P < 0.05; **P < 0.01; 
***P < 0.001.
Data availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files).
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